Weekly Journal of Sickle Cell Disease Publication Update

Stay current with the latest sickle cell research, regulatory updates, and guidelines.

Transition to Adult Sickle Cell Disease Care: A Project ECHO Learning Series for Healthcare Professionals

04.1.26

To evaluate whether a structured Project ECHO virtual learning series could improve healthcare professionals’ knowledge and confidence in facilitating transition from pediatric to adult care for patients with sickle cell...

Soluble C5b-9 as a Biomarker for Hemolysis-Associated Complications in Sickle Cell Disease

03.25.26

To evaluate soluble C5b-9 (sC5b-9), a marker of terminal complement activation, as a biomarker for hemolysis-associated complications in sickle cell disease (SCD).

Placental Contributions to Pregnancy Outcomes in the Townes Mouse Model of Sickle Cell Disease

03.18.26

To investigate how placental pathology contributes to adverse pregnancy outcomes in sickle cell disease (SCD).

Non-Genotoxic Conditioning to Improve Donor Chimerism in a Mismatched Murine Transplant Model for Sickle Cell Disease

03.11.26

To evaluate whether non-genotoxic antibody-drug conjugate (ADC) conditioning can support donor hematopoietic engraftment in a murine sickle cell disease (SCD) transplant model.

A Phase 1b, Open-label, Multiple-Dose Study Evaluating Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Pociredir in Patients With Sickle Cell Disease (SCD): Trial Design

03.4.26

To assess safety, pharmacokinetics (PK), pharmacodynamics (PD), and biologic activity of pociredir in patients with SCD, including effects on fetal hemoglobin (HbF) and hemolysis.

Breast cancer screening in women with SCD: a single-center exploratory study

02.25.26

To evaluate breast cancer screening utilization and mammographic characteristics among women living with sickle cell disease (SCD).

Preliminary observations on cerebral blood flow and pain sensitivity in adults with SCD

02.18.26

To explore the relationship between cerebral blood flow (CBF) and pain sensitivity in adults with sickle cell disease (SCD).

Elevated ambient nitrogen dioxide (NO₂) levels were associated with greater odds of abnormal pulmonary function tests in children and young adults with sickle cell disease (SCD), highlighting an environmental factor that may influence respiratory health in this population.

02.4.26

To evaluate whether ambient air pollution exposures, particularly criteria pollutants, are associated with abnormal pulmonary function tests (PFTs) among young people living with SCD.